Multinucleated Giant Cells Are Specialized for Complement-Mediated Phagocytosis and Large Target Destruction  by Milde, Ronny et al.
ArticleMultinucleated Giant Cells Are Specialized for
Complement-Mediated Phagocytosis and Large
Target DestructionGraphical AbstractHighlightsd MGCs are specialized for phagocytosis of large and
complement-opsonized particles
d MGCs show extensive membrane ruffles containing pre-
activated complement receptor 3
d Membrane ruffles provide excess membrane for ingestion of
large materials
d MGCs eliminate systemic amyloid deposits after
immunotherapeutic targetingMilde et al., 2015, Cell Reports 13, 1937–1948
December 1, 2015 ª2015 The Authors
http://dx.doi.org/10.1016/j.celrep.2015.10.065Authors
Ronny Milde, Julia Ritter,
Glenys A. Tennent, ..., Mark B. Pepys,
Admar Verschoor, Laura Helming
Correspondence
m.pepys@ucl.ac.uk (M.B.P.),
admar.verschoor@uksh.de (A.V.)
In Brief
Macrophage-derived multinucleated
giant cells (MGCs) form in diverse chronic
inflammatory diseases, but their
functional role remains unclear. Milde
et al. show that MGCs are specialized for
complement-mediated phagocytosis and
destruction of large targets and
demonstrate their key role in the
therapeutic elimination of the pathogenic
amyloid deposits in systemic
amyloidosis.
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Multinucleated giant cells (MGCs) form by fusion of
macrophages and are presumed to contribute to
the removal of debris from tissues. In a systematic
in vitro analysis, we show that IL-4-induced MGCs
phagocytosed large and complement-opsonized
materials more effectively than their unfused M2
macrophage precursors. MGC expression of com-
plement receptor 4 (CR4) was increased, but it func-
tioned primarily as an adhesion integrin. In contrast,
although expression of CR3 was not increased, it
became functionally activated during fusion and
was located on the extensive membrane ruffles
created by excess plasma membrane arising from
macrophage fusion. The combination of increased
membrane area and activated CR3 specifically
equips MGCs to engulf large complement-coated
targets. Moreover, we demonstrate these features
in vivo in the recently described complement-depen-
dent therapeutic elimination of systemic amyloid de-
posits by MGCs. MGCs are evidently more than the
sum of their macrophage parts.
INTRODUCTION
Multinucleated giant cells (MGCs), first described in tuberculosis
(Langhans, 1868), are also present in diverse infectious and non-
infectious chronic inflammatory conditions, including schistoso-
miasis, atherosclerosis, sarcoidosis, and Langerhans cell histio-
cytosis (Helming and Gordon, 2009; Samokhin et al., 2010).
MGCs also typify the foreign body reaction to macroscopic
organic and inorganic materials, such as uric acid crystals and
surgical implants (Helming and Gordon, 2009; Lai and Zhou,
2013). MGCs and osteoclasts are derived by cell-cell fusion ofCell Remacrophages. Formation of osteoclasts, essential for bone
resorption, is mediated by receptor activator of nuclear factor
kappa-B ligand (RANKL) and macrophage colony-stimulating
factor (M-CSF). Factors inducing MGC formation are less well
defined (Helming and Gordon, 2009), but interleukin-4 (IL-4), a
TH2 cytokine of alternative (M2) macrophage activation, induces
fusion in vitro and in sarcoidosis and foreign body reactions
in vivo (Kao et al., 1995; Prokop et al., 2011). The role of MGCs
in disease is also obscure, and it remains unclear whether they
are beneficial or detrimental to disease outcome. It cannot be
excluded that fused macrophages exhibit different roles de-
pending on the nature of the disease. As they are often found un-
der conditions where large and/or poorly degradable material is
present (e.g., implants and uric acid crystals), there is specula-
tion about specialization of MGCs for uptake of large particles
(Anderson et al., 2008), but there are no rigorous quantitative
studies. Indeed, reduced (Chambers, 1977; Lay et al., 2007),
increased (Moreno et al., 2007; Nakanishi-Matsui et al., 2012),
or unchanged (Schlesinger et al., 1984) phagocytic activity of
MGCs compared to non-fused macrophages have all been re-
ported. However, all of these studies lacked unambiguous
discrimination between fully ingested particles and those loosely
attached to the external cell surface. Here, we report a direct and
well-controlled systematic comparison of the phagocytic activity
of MGCs and M2 macrophages in vitro and characterize the
cellular mechanisms underlying the unique functional behavior
of MGCs.
Furthermore, we demonstrate these features in vivo in the
recently described complement-dependent therapeutic elim-
ination of systemic amyloid deposits by MGCs. This process
is characterized by antibody-mediated complement activa-
tion and opsonization of amyloid deposits, triggering macro-
phage infiltration and formation of MGCs, which efficiently
eliminate the amyloid (Bodin et al., 2010; Richards et al.,
2015). We show here that this therapeutic process involves
the same phenotypic features of MGCs that characterize
them in vitro.ports 13, 1937–1948, December 1, 2015 ª2015 The Authors 1937
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Figure 1. Phagocytosis of Complement-
Opsonized RBCs by MGCs Is Increased
when Compared to Unfused M2 Macro-
phages
(A) Macrophage fusion induced by IL-4
treatment of BMMs, Hemacolor staining,
observed in bright field microscopy. Dashed
lines indicate MGCs. The scale bar represents
200 mm.
(B) Discrimination of external and internalized
phagocytic targets. External IgG-opsonized
RBCs were immunostained with anti-rabbit
DyLight549 antibodies (red) and external com-
plement-opsonized RBCs with anti-iC3b and
Alexa-488-labeled secondary antibodies (green).
Arrows indicate non-ingested (black) or ingested
(white) particles. Nuclei are counterstained with
Hoechst (blue). Results were viewed in fluores-
cence microscopy. The scale bar represents
20 mm.
(C) Quantification of internalized particles in un-
fused macrophages and MGCs after 1 hr of
phagocytosis, particle per cell ratio.
(D) Quantification of internalized particles, parti-
cle per nucleus ratio.
(E) Phase contrast image overlaid with nuclear
staining (Hoechst; blue) after incubation with
complement-opsonized RBCs. RBCs (arrows)
are mainly detected in MGCs (dashed lines). The
scale bar represents 50 mm.
(F) Involvement of C3 in phagocytosis of serum-
opsonized RBCs. RBCs were left unopsonized or
opsonized with FVB/N (C5-deficient) serum or
serum from C3-KO mice and added to the MGC/
macrophage cultures for 1 hr.
Internalized RBCs were quantified and normal-
ized to the number of nuclei (C, D, and F) and shown asmean ±SEM; n = 25. Results are representative of greater than or equal to three independent experiments.
Statistical comparison was with macrophages under the same conditions. ***p < 0.001; two-tailed Student’s t test.RESULTS
MGCs Exhibit Enhanced Phagocytic Activity toward
Complement-Opsonized Targets
Fusion of murine primary bone marrow-derived macrophages
(BMMs) was induced by IL-4 (Figure 1A), resembling M2 macro-
phage activation, and the phagocytic capacities of fused and
non-fused macrophages were evaluated with sheep red blood
cells (RBCs) opsonized either with IgG anti-RBC antibody alone
or with IgM anti-RBC antibody followed by fresh whole C5-defi-
cient mouse serum to provide complement. Specific fluores-
cent-labeled antibodies directed against the opsonizing agent
(Figure 1B) were used to discriminate between bound and inter-
nalized particles. Significantly more RBCs were internalized per
multinucleated cell than per non-fused mononucleated M2-acti-
vated macrophage of the same culture, both for complement
and IgG opsonins (Figure 1C). However, when the numbers of
internalized RBCs were normalized to the number of fused mac-
rophages per MGC, determined by the number of nuclei present,
these remained much higher only for serum-opsonized particles
(Figures 1D and 1E). For IgG-opsonized RBCs, the particle/nu-
cleus ratio was comparable between MGCs and unfused M2
macrophages (Figure 1D). When C3-deficient serum was used1938 Cell Reports 13, 1937–1948, December 1, 2015 ª2015 The Autfor opsonization, phagocytosis was comparable to that of non-
opsonized RBCs, confirming that C3 fixation was essential for
enhanced uptake (Figure 1F).
MGCs Are Specialized for Phagocytosis of Large
Particles
The phagocytic capacity of fused and unfusedM2macrophages
for non-organic particles of different sizes was compared using
defined diameter, 0.5, 2, 4.5, 10, and 20 mm, polystyrene beads,
with immunostaining to exclude non-internalized particles (Fig-
ure 2A). Normalizing the number of phagocytosed beads to the
number of nuclei per MGC, beads of up to 4.5 mm were phago-
cytosed at comparable rates by M2-activated mono- and multi-
nucleated macrophages (Figure 2B). In contrast, beadsR10 mm
were preferentially taken up by MGCs in mixed cultures (Figures
2B and 2C), even thoughmacrophages have been reported to be
able to ingest 20-mm beads (Cannon and Swanson, 1992).
Beads of 45 mm diameter are arguably too large to be phagocy-
tosed by individual macrophages, and their uptake was detected
only in MGCs (Figure 2D), with complete ingestion confirmed by
3D visualization of confocal microscopy images (Figures S1A
and S1B; Movies S1 and S2). The MGCs were evidently special-
ized for phagocytosis of large targets, but this was not simply ahors
AB
C D
E F
Figure 2. MGCs Are Specialized for the Phagocytosis of Large Particles
(A) Detection of external rabbit IgG-coated latex beads. External beads were immunostained with anti-rabbit DyLight549 antibodies (red), nuclei were coun-
terstained with Hoechst (blue), and results viewed by fluorescence microscopy. Arrows indicate non-ingested (black) or ingested (white) particles. The scale bar
represents 30 mm.
(B) Quantification of internalized beads of different sizes in macrophages and MGCs after 1 hr or 24 hr (20-mm beads) exposure, normalized to the nucleus count
(n = 25). To illustrate absolute sizes of the different types of beads, phase contrast images overlaid with nuclear staining (Hoechst; blue) are shown. For
quantification of internalized 0.5-mm beads, cells were permeabilized after staining and fixation and beads (re-)stained with Alexa-488-labeled anti-rabbit an-
tibodies. The scale bar represents 30 mm.
(C) Phase contrast image overlaid with immunostaining of external beads (DyLight549-labeled anti-rabbit antibodies; red) after incubation with 20-mm IgG beads.
Beads were concentrated within MGCs. The scale bar represents 100 mm.
(D) Detection of internalized 45-mm IgG-coated beads. Staining was performed as described in (A). Arrows indicate non-ingested (black) or ingested (white)
particles. The scale bar represents 40 mm.
(E) Bead uptake in MGCs grouped according to their nucleus count. Internalized beads were quantified in MGCs with 3–9, 10–19, 20–29, andR30 nuclei (n = 20).
(F) Uptake of 20-mm IgG-coated latex beads in osteoclasts (Ost) and macrophages within the same culture, beads per nucleus ratio (n = 14).
Shown aremeans ±SEM. Results are representative of greater than or equal to three independent experiments. *p < 0.05; ***p < 0.001; two-tailed Student’s t test.
See also Figure S1 and Movies S1 and S2.
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Figure 3. MGCs Show a Reduced Uptake of
IgG-Opsonized RBCs Under Inflammatory
Conditions
(A) Quantification of internalized particles in
thioglycollate-elicited peritoneal macrophages
(ThioMs) and ThioM-derived MGCs, normalized to
the number of nuclei.
(B) Detection of internalized 45-mm IgG-coated
latex beads. External beads were immuno-
stained with anti-rabbit IgG DyLight549 anti-
bodies (red), nuclei were counterstained with
Hoechst (blue), and results were viewed by fluo-
rescence microscopy. Internalized particles (white
arrow) appear unstained and external (black
arrow) in red.
(C) Internalized IgG-opsonized RBCs in untreated
and cells pretreated with LPS (10 ng/ml) for 24 hr,
normalized to the number of nuclei.
Results in (A) and (C) are shown as mean ± SEM,
n = 25, and are representative of greater than
or equal to three independent experiments. *p <
0.05; **p < 0.01; ***p < 0.001; two-tailed Student’s
t test.function of the larger cell size: with 20-mm beads, there was no
significant difference in the internalized bead/nucleus ratio be-
tweenMGCswith 3–9, 10–19, 20–29, andR30 nuclei (Figure 2E),
demonstrating that phagocytosis of these large particles by
MGCs was independent of cell size. Internalization of large par-
ticles is therefore an inherent trait of MGCs, distinctly different
from their mononuclear M2 macrophage precursors.
In the aforementioned studies, beads that were covalently
coated with nonspecific IgGs were used to aid their extra/intra-
cellular detection. Beads with nonspecific, chemically bound
IgG are internalized independently of Fc receptors (Michl et al.,
1983). Uptake by MGCs of 10- and 20-mm beads coated with
the irrelevant protein ovalbumin was equally increased, confirm-
ing that ingestion of these large beads was not dependent on Fc
receptors (Figure S1C). Furthermore, bead internalization by
MGCs was completely blocked by inhibition of actin polymeriza-
tion and PI3 kinase, confirming a bona fide phagocytosis pro-
cess by MGCs (Figure S1D). Larger 20- and 45-mm beads
were phagocytosed more slowly than smaller particles, but,
although incubation times had to be extended from 1 to 24 hr,
the macrophage fusion index did not differ before and after incu-
bation, confirming that internalization was indeed due to phago-
cytosis and not to fusion ofmacrophages around the large beads
(Figure S1E). Interestingly, osteoclasts generated by treatment
of macrophages with RANKL and M-CSF also efficiently phago-
cytosed 20-mm beads (Figure 2F), demonstrating that fusion of
macrophages into multinucleated cells, mediated by different
stimuli, leads to a generally enhanced ability to phagocytose
large targets.
Inflammatory Conditions Stimulate IgG-Mediated
Phagocytosis by Macrophages, but Not MGCs
The BMMs used to produce MGCs in vitro are resting macro-
phages, but in vivo MGCs generally form under chronic inflam-1940 Cell Reports 13, 1937–1948, December 1, 2015 ª2015 The Autmatory conditions (Helming and Gordon, 2009). Thioglycollate-
elicited inflammatory macrophages (ThioMs) were therefore
tested and, as with BMM-MGCs (Figures 1 and 2), ThioM-
derived IL-4-induced MGCs showed a clearly increased uptake
of complement-opsonized RBCs (Figure 3A) as well as large
polystyrene beads (Figures 3A and 3B). In contrast, ThioM-
MGCs showed reduced phagocytosis of IgG-opsonized parti-
cles (Figure 3A). When IgG-opsonized particles were offered to
BMMs and BMM-MGCs after exposure to LPS as an inflamma-
tory stimulus in vitro, there was increased uptake by unfused
macrophages, but not by MGCs (Figure 3C). Inflammatory con-
ditions thus did not affect increased phagocytosis of comple-
ment-opsonized and large objects by MGCs, and IgG-mediated
phagocytosis was increased only in macrophages.
Physical Separation of MGCs from Unfused
Macrophages Enables Direct Comparison of Phagocytic
Receptor Expression
IL-4-induced BMM fusion on non-treated tissue culture plastic
(Jay et al., 2007) allowed the detachment of macrophages and
MGCs (Rosen and Gordon, 1987) and their separation on 30-
and 10-mm pore size sieves (Figure 4A) into the two pure cell
populations as seen in bright field microscopy (Figure 4B). This
method enabled direct western blot comparisons of the expres-
sion of all four murine IgG receptors (FcgR) and complement re-
ceptors 3 (CR3) (CD11b/CD18) and 4 (CR4) (CD11c/CD18) on
MGCs and M2 macrophages they derive from. Importantly,
these cell populations were from the same culture and thus
grown under the same conditions. Consistent with the reduced
uptake of IgG-opsonized RBCs in MGCs (Figure 3C), there was
reduced FcgRIIb and FcgRIV expression in fused compared to
unfused macrophages under inflammatory conditions (Fig-
ure 4C). FcgRI and FcgRIII levels were unchanged. Complement
receptor CD11bwas similarly expressed in both populations, buthors
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Figure 4. Altered Phagocytic Activity of
MGCs Toward IgG- and C3-Opsonized
RBCs Correlates with Protein Expression
of the Respective Phagocytic Receptors
(A) Experimental approach for separation of mac-
rophages and MGCs from a mixed culture. BMMs
were induced to fuse by exposure to IL-4 on non-
treated tissue culture plastic, detached, and
separated using cell sieves with 30- and 10-mm
pore size.
(B) Hemacolor-stained preparations before and
after separation, viewed in bright field microscopy.
(C) Comparison of expression of FcgRI, FcgRIIb,
FcgRIII, and FcgRIV by western blotting of lysates
of the separated cell populations. Cells were pre-
treated with LPS (10 ng/ml) for 24 hr before lysis.
(D) Comparison of CD11b, CD11c, and CD18
expression by western blot.
In (C) and (D), actin was used as loading control.
Results are representative of greater than or equal
to three independent experiments.expression of both CD11c and CD18 was greater in MGCs (Fig-
ure 4D), suggesting a possible role for CR4 (CD11c/CD18) in the
increased uptake of C3-opsonized RBCs (Figure 1D).
FcgRIV Promotes Phagocytosis of IgG-Opsonized
Targets
Blocking the different FcgR subtypes in phagocytosis using spe-
cific anti-FcgR antibodies showed that the uptake of IgG-opson-
ized RBCs by macrophages was largely dependent on FcgRIV
(Figure S2A) whereas blockade of FcgRIIb/III had no significant
effect (Figure S2B). Combined with the observed reduction in
FcgRIV protein expression (Figure 4C), these results indicate
that reduced IgG-dependent phagocytosis by MGCs under in-
flammatory conditions (Figure 3C) reflects their reduced FcgRIV
expression.
CD11c/CD18 Expression Increases in Alternatively
Activated Macrophages and Substitutes for
CD11b/CD18 Integrin Adhesion
Surprisingly, although CR4 expression was found to be in-
creased in MGCs (Figure 4D), there was no reduction in phago-
cytosis after treatment of MGCs with CD11c-blocking antibody
(Figure 5A) or inMGCs derived fromCD11c-KOmice (Figure 5B).
Unrelated to its role in phagocytosis of complement-opsonized
particles, complement receptor CR4 (CD11c/CD18) is an integrin
involved in cellular adhesion. Indeed, consistent with the
increased expression of CD11c/CD18 by MGCs, there was
extensive cell spreading of IL-4-induced MGCs immediately af-
ter plating on non-treated plastic, a surface where cell adhesion
is integrin dependent (Rosen and Gordon, 1987). Unfused M2Cell Reports 13, 1937–1948, Dmacrophages from the same culture re-
tained a rounded shape typical of poorly
adherent cells for the first few hours (Fig-
ure 5C). Expression of CD11c/CD18 pro-
tein was strongly upregulated by IL-4
stimulation, compared to macrophages
kept in the presence of M-CSF as thecrucial growth/survival factor, whereas expression of CD11b/
CD18was not affected (Figure 5D). Consistent with these protein
findings, blocking antibodies to CD11b and CD18 inhibited
adhesion of M-CSF macrophages (Figure 5E), as previously re-
ported (Rosen and Gordon, 1987), but neither anti-CD11b nor
anti-CD11c alone affected adhesion of MGCs or their M2macro-
phage precursors (Figure 5F). Only combined CD11b andCD11c
blockade or blockade of their common CD18 partner abolished
cell adhesion in the presence of IL-4. Furthermore, M2 macro-
phages derived from either CD11b- or CD11c-knockout mice
exhibited normal cell adhesion, but antibody blockade of the
respective complementary integrin abolished adhesion (Fig-
ure 5G). Evidently and in contrast to M-CSF macrophages,
CD11c/CD18 and CD11b/CD18 can substitute for each other
in cell adhesion of IL-4-induced M2 macrophages and their
MGC products, and the strongly increased CD11c/CD18
expression of M2 macrophages and MGCs (Figures 4D and
6D) allows for CD11c/CD18-mediated integrin adhesion, shifted
away from the purely CD11b/CD18-mediated integrin adhesion
observed for M-CSF macrophages. The enhanced spreading
of MGCs relative to their M2 macrophage precursors (Figure 5C)
appears connected to their elevated expression of CD11c/CD18
whereas the enhanced phagocytosis of complement-opsonized
targets by MGCs is independent of CD11c.
Increased Uptake of Large and C3-Opsonized Targets
by MGCs Is Enabled by Activated CR3 and Extensive
Membrane Ruffling
In contrast to CR4, blockade of complement receptor CR3
completely abolished the increased uptake of C3-opsonizedecember 1, 2015 ª2015 The Authors 1941
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Figure 5. Alternative Macrophage Activation Increases CR4 Expression, which Can Substitute for CR3 in Integrin-Dependent Adhesion
(A) Effect of CR4 (CD11c)-blocking antibodies on phagocytosis of complement-opsonized RBCs. MGC/macrophage cultures were preincubated with anti-
CD11c (N418) or isotype control antibodies for 30 min on ice before addition of opsonized RBCs.
(B) Phagocytosis of complement-opsonized RBCs in fused and unfused macrophages from CD11c-KO mice. (A) and (B) show means ± SEM, n = 25, and
statistical comparison with isotype (A) or WT (B) controls.
(C) Separated macrophages and MGCs (dashed lines) were plated on non-treated plastic for readhesion. After 3 hr at 37C, non-adherent cells were washed off
and images acquired by phase contrast microscopy. The scale bar represents 50 mm.
(D) Three-day-old BMMs were cultured for further 3 days with M-CSF or with IL-4 instead on tissue-culture-treated plastic (non-fusogenic), immunostained with
anti-CD11c-PE or anti-CD11b-APC antibodies, and analyzed by flow cytometry.
(E–G) Cultures of WT (E and F) or knockout (G) cells were incubated with M-CSF or IL-4 for 3 days. Macrophages andMGC were separated and plated onto non-
treated plastic for re-adhesion in the presence or absence of blocking antibodies, CD18 (GAME-46), CD11b (5C6), and CD11c (N-418) or isotype controls. After
3 hr, cells were washed and stained with crystal violet and results viewed by bright field microscopy.
All results are representative of greater than or equal to three independent experiments. See also Figure S2.RBCs by MGCs (Figure 6A), and such uptake was also absent
in MGCs derived from BMMs of CD11b-knockout mice (Fig-
ure 6B). Despite the strict dependence of the enhanced capacity
on CR3 for complement-mediated phagocytosis in MGCs, CR3
protein levels were not increased in MGCs (Figure 4D). However,
CR3 is an integrin (Itgam/Itgb2) subject to bi-directional (inside-
out and outside-in) signaling. PMA, which induces CR3 activa-
tion through inside-out signaling (Caron et al., 2000), markedly1942 Cell Reports 13, 1937–1948, December 1, 2015 ª2015 The Autincreased phagocytosis of C3-opsonized targets by unfused
M2 macrophages but remarkably had no effect on their phago-
cytosis by MGCs (Figure 6C). Apparently CR3 on MGCs is in a
pre-activated state and does not require further external stimuli
to mediate maximally efficient phagocytosis.
Efficient phagocytosis via CR3 on PMA-activated macro-
phages has previously been shown to be facilitated by extensive
plasma membrane ruffles (Patel and Harrison, 2008). The CR3hors
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Figure 6. Activated CR3 and Extensive Membrane Ruffling Enable Increased Uptake of C3-Opsonized RBCs and Large Particles by MGCs
(A) MGC/macrophage cultures were preincubated with CR3-blocking (anti-CD11b; 5C6) or isotype control antibodies (on ice; 30 min) before RBC addition.
(B) Phagocytosis of complement-opsonized RBCs by CD11b-deficient macrophages/MGCs.
(C) Internalized complement-opsonized RBCs in the absence/presence of PMA (150 ng/ml) after 1 hr of phagocytosis, normalized to the nucleus count. Results
are shown asmean ± SEM, n = 25, and are representative of greater than or equal to three independent experiments. *p < 0.05; **p < 0.01; ***p < 0.001; two-tailed
Student’s t test.
(D) (Top) Macrophages/MGCs (dashed lines) were stained with anti-CD11b, Alexa-488-labeled secondary antibodies (green), and nuclei counterstained with
Hoechst (blue). The scale bar represents 20 mm. (Bottom) MGC stained with ConA-Alexa-488 (white; detail) is shown. Confocal images are shown as merged z
stack. The scale bar represents 10 mm.
(E) (Top) Macrophages treated with PMA (150 ng/ml) for 1 hr were stained as described in (D) (top). Confocal optical sections are depicted in detail. The scale bar
represents 5 mm. (Bottom) Macrophages treated without/with PMA (150 ng/ml) for 1 hr were stained for polymerized actin with phalloidin-TRITC (white). Confocal
images are shown as merged z stack. Arrows indicate membrane ruffles. The scale bar represents 10 mm.
(F) MGCs were stained with phalloidin-TRITC (white) and Hoechst (blue) and images taken by fluorescence microscopy. Arrows indicate actin-containing
membrane ruffles. The scale bar represents 10 mm.
(G) 3D surface projection of a detailed section from (D) (bottom) generated by Imaris software. The scale bar represents 1 mm.
See also Movies S3 and S4.
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Figure 7. Complement Activation on Amyloid Deposits In Vivo Triggers Their Elimination by MGCs
Representative histology and IHC of spleen and liver from AA amyloidotic mice that received a single dose of complement fixing anti-SAP antibodies and were
sacrificed at intervals thereafter.
(A) Within 24 hr of treatment, amyloid deposits (CR-birefringence) in the splenic perifollicular marginal zone and hepatic portal tracts were surrounded and
robustly infiltrated by F4/80+ macrophages (a-F4/80). The scale bars represent 100 mm.
(B) At days 1 or 2, the macrophages fused to form MGCs (spleen, dashed lines; scale bar represents 20 mm) that aligned closely to the extracellular amyloid
(arrows). Amyloid (arrows) could also be seen inside someMGCs (liver, Congo-red; scale bar represents 50 mm). Transmission electron microscopy revealed the
presence of extensive membrane ruffling on amyloid-laden MGCs (scale bar represents 2 mm; enlargement highlights membrane ruffling). Immunoelectron
micrographs showedMGCs actively ingesting complement-opsonized AA amyloid (ImmEM a-AA) and phagosomes containing internalized C3d-positive amyloid
fibrils inside MGCs (ImmEM a-C3d); scale bars represent 1 mm. A, amyloid; N, nucleus. Accompanying cartoons highlight the peripheral contours and relevant
features of adjacent TEM images.
(legend continued on next page)
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molecules of unstimulated MGCs, identified by confocal micro-
scopy, were indeed located on just such membrane ruffles
(Figure 6D), which closely resembled those on PMA-treated
macrophages (Figure 6E). Ruffles, bearing abundant CR3, both
on PMA-activated macrophages and MGCs, were rich in poly-
merized actin, and could be even visualized by light micro-
scopy without staining (Figure 6F). Furthermore, 3D surface
projection of confocal microscopy z stacks clearly showed the
three-dimensional protrusion of ruffles from the surface of unsti-
mulated MGCs (Figure 6G; Movies S3 and S4). Importantly,
membrane ruffles provide a scaffold to which pre-activated
CR3 localizes for efficient complement-mediated phagocytosis
(Patel and Harrison, 2008) and also supply the excess cellular
membrane necessary to cover and engulf large particles during
phagocytosis (Cannon and Swanson, 1992). The extensive
membrane ruffling present onMGCs in their natural unstimulated
state was absent in surrounding unfused M2 macrophages,
illustrating the unique and distinctive phenotype of MGCs that
allows them to efficiently engulf large, complement-opsonized
materials.
MGC Formation Accompanies Phagocytosis of
Complement-Opsonized AA Amyloid Deposits In Vivo
Systemic amyloid A (AA) amyloidosis induced in mice by chronic
inflammation closely resembles human AA amyloidosis. After
histochemical staining with Congo red, the amyloid deposits,
located in the splenic marginal zone and in hepatic periportal re-
gions, exhibit pathognomonic bright green birefringence when
viewed in intense cross-polarized light (Figure 7A). When these
murine amyloid deposits were loaded with human serum amy-
loid P component (SAP) in vivo, administration of a single dose
of complement-activating IgG anti-human SAP antibody trig-
gered massive infiltration of F4/80-positive macrophages within
24 hr (Bodin et al., 2010; Figure 7A). In contrast, cellular infiltra-
tion was conspicuously and characteristically absent from the
deposits of control amyloidotic mice receiving either no treat-
ment or an irrelevant IgG antibody (Bodin et al., 2010). The infil-
trating cells in anti-SAP-antibody-treated mice were initially only
weakly positive for CD11b (Figure 7A) and the phagosome-lyso-
somemarker CD68 (not shown), but within 1 or 2 days, there was
extensive fusion to form MGCs with strong CD68 immunoreac-
tivity (Bodin et al., 2010), and the majority of these were closely
associated with the amyloid substance (Figure 7B). Indeed, am-
yloid was present within the cytoplasm of some cells (Figure 7B),
and immunoelectron microscopy showedMGCs actively ingest-
ing amyloid (Figure 7B). Moreover, extensive membrane ruffling,
as seen in vitro (Figure 6), was present on MGCs that formed
in vivo in relation to the amyloid deposits (Figure 7B). As ex-
pected, the MGCs were immunoreactive for F4/80, confirming
their macrophage origin (Figure S3). Amyloid fibrils within phag-
osomes were positive for C3d (Figure 7B), confirming comple-
ment activation and deposition on the amyloid target, consistent(C) By days 3 or 4, extracellular amyloid was much reduced and fragmented (CR
were now larger and their cytoplasm was filled with amyloid (Congo-red: congop
CR-birefringence; H&E: eosinophilic intracellular amyloid; scale bars represent
100 mm). Asterisks, amyloid-laden MGCs distant from original areas of amyloid d
Scale bars on the first LHS image of each panel in (A)–(C) apply also to adjacent
Cell Rewith our previous demonstration in C1q- or C3-deficient mice
that antibody-mediated elimination of amyloid was complement
dependent (Bodin et al., 2010). By 3 or 4 days after anti-SAP
treatment, there was a dramatic increase in macrophage
fusion and in the size of the MGCs, which were surrounding
and fragmenting the amyloid. Overall amyloid load wasmarkedly
reduced, and the residual deposits showed only dull green
birefringence (Figure 7C). The majority of MGCs appeared
completely filled with intracellular amyloid (Figure 7C), which
was within multiple phagosomes and immunostained for the
AA fibril protein (Bodin et al., 2010). We previously reported
strong immunoreactivity of MGCs at this stage for CD68 (Bodin
et al., 2010), the marker of phagolysosome fusion, and here,
we observed an additional strong immunoreactivity for CD11b,
peaking at this time point (Figure 7C). Some MGCs were no
longer located adjacent to the original areas of amyloid deposi-
tion, and few mononuclear macrophages were found here
also. By day 14, almost no amyloid was detectable and normal
splenic and hepatic architecture was restored (Bodin et al.,
2010). Crucially, the whole process was clinically silent with no
adverse clinical, hematological, or biochemical effects observed
in any recipient of the treatment.
DISCUSSION
Since the first description of MGCs in 1868, there have been few
attempts to investigate their specific properties or to clarify their
function. Different in vitro macrophage fusion systems (Helming
andGordon, 2007; Jay et al., 2007;McNally and Anderson, 1995)
and fusion effector molecules have been identified (Aguilar et al.,
2013; Helming and Gordon, 2009). However, none of these mol-
ecules are unique to fusingmacrophages so they cannot be used
in knockout approaches to prevent MGC formation and to inves-
tigate MGC function in vivo. Here, we studied mixed M2-acti-
vated macrophage-MGC cultures in vitro, combined with a
method we established to separate MGCs and unfused macro-
phages from the same culture, and thus directly link phagocy-
tosis and phagocytic receptor expression by the two related
cell types. We found that MGCs phagocytosed IgG-opsonized
RBCs less avidly than unfused M2 macrophages, consistent
with our finding of reduced FcgR expression in MGCs. In
contrast, MGCs were remarkably more competent in the uptake
of large particles and were specifically equipped for phagocy-
tosis of complement-opsonized targets via activated CR3.
Activation of CR3 is a prerequisite for efficient ingestion of
complement-opsonized particles (Bianco et al., 1975) and can
be induced by PMA or via adhesion of macrophages to permis-
sive surfaces (Wright et al., 1983). Interestingly, although Wright
et al. (1983) reported SAP to be such a permissive surface
coating in vitro, macrophages almost never adhere spontane-
ously to amyloid fibrils in vivo, despite all such fibrils being invari-
ably coated with SAP. This observation is consistent with the-birefringence; scale bars represent 100 mm). In parallel, MGCs (dashed lines)
hilic intracellular amyloid; arbitrary bright field enlargement of boxed area from
20 mm). They also strongly expressed CR3 (a-CD11b; scale bars represent
eposition.
images unless indicated otherwise. See also Figure S3.
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marked anti-opsonic effect of SAP coating of bacteria (Noursa-
deghi et al., 2000). Distinct from phagocytosis, the adhesion pro-
cess itself is also important for macrophage fusion (Helming and
Gordon, 2007; McNally and Anderson, 2002), and CD44, an
adhesion receptor for several extracellular matrix components,
is among the receptors associated with MGC formation (Sterling
et al., 1998). In vitro, macrophage binding of the CD44 ligand
hyaluronan or treatment of the cells with anti-CD44 antibodies
increases CR3 activation and enhances phagocytosis of com-
plement-opsonized RBCs (Vachon et al., 2007). The increased
activation of CR3 in MGCs reported here may thus reflect
specialized adhesion processes associated with macrophage
fusion.
In addition to pre-activated CR3, we identified extensivemem-
brane ruffling on unstimulated MGCs as a critical structural
feature required for their capacity to engulf large targets. Impor-
tantly, CR3 was located on these ruffles. Membrane ruffling is an
induced, active process involving actin polymerization, and such
extensive ruffles, capturing RBCs for phagocytosis, have previ-
ously been reported only on PMA-activated macrophages (Patel
and Harrison, 2008). Ruffling provides an increased surface
area for particle attachment via ligation to phagocytic receptors,
and its induction is evidently closely related to fusion of macro-
phages into MGCs. The actin polymerization-associated small
GTPase, Rac1, is required for both membrane ruffle formation
in macrophages (Ridley et al., 1992) and for formation of
MGCs (Gonzalo et al., 2010; Jay et al., 2007). Moreover, the
membrane protrusions, which were necessary for cell-cell fusion
(Shilagardi et al., 2013), were lacking on osteoclasts of severely
osteopetrotic Rac1/Rac2 knockout mice (Croke et al., 2011).
Taken together, these observations indicate that MGC ruffle for-
mation may be a direct consequence of the macrophage fusion
process.
Distinct from signaling pathways, ruffles and the excess
plasma membrane they provide are physically necessary for
the ingestion of large materials by macrophages (Cannon and
Swanson, 1992), especially in cases where particle volume ex-
ceeds the cell volume (Champion and Mitragotri, 2006). The
inherent membrane ruffling of MGCs is also evidently crucial
for their capacity to phagocytose large particles and to engulf
non-particulate targets of varying sizes. Cell fusion inevitably in-
creases the surface area:volume ratio. For example, a smoothly
spherical MGC derived from 50 spherical macrophages would
have only 27% of the original total membrane area (Figure S4).
The excess membrane generated on fusion thus becomes avail-
able as membrane ruffles, providing a scaffold for activated CR3
and enabling engulfment of large and complement-opsonized
materials.
We show here that CR4, a major complement receptor on
macrophages and MGCs, is not required for the phagocytosis
of complement-opsonized targets. Nonetheless, functioning as
the CD11c/CD18 integrin, CR4 can substitute for CR3 (CD11b/
CD18) in mediating adhesion stimulated by IL-4. IL-4 also trig-
gers formation of MGCs in culture in vitro and during the foreign
body reaction in vivo (Kao et al., 1995). In such a TH2-dominated
environment, MGCs may thus utilize CR4 for cell adhesion,
freeing pre-activated CR3 for phagocytosis of complement-
coated targets. Indeed, strongly upregulated CR4 expression1946 Cell Reports 13, 1937–1948, December 1, 2015 ª2015 The Autmay have amore-important role during the foreign body reaction
than previously considered. Binding of plasma proteins (Kourt-
zelis et al., 2013), especially complement proteins (Tang et al.,
1998), to surgical implants contributes substantially to their
pro-inflammatory effects. Complement receptor-mediated cell
adhesion to biomaterials may be particularly significant for
foreign targets, such as metal or polymer implants, that do not
have intrinsic ligands for phagocytic cell receptors. Importantly,
these complement proteins are not necessarily plasma derived
as macrophages and other myeloid cells can produce them
locally (Feldmann and Pepys, 1974; Gadjeva et al., 2002; Kopf
et al., 1998; Verschoor et al., 2001, 2003).
Macrophages and MGCs are also crucial for the clinically si-
lent physiological clearance of autologous debris and for tissue
remodeling after injury, such as the elimination of hematomas
or the remodeling of bone, respectively. Furthermore, as previ-
ously reported, macrophage-derived MGCs play a key role in
antibody-mediated clearance of amyloid in vivo in a humanized
mouse model of systemic amyloidosis (Bodin et al., 2010). In
serial histological, immunohistochemical, and electron micro-
scopic studies over the days after a single dose of anti-SAP anti-
body, almost all ingestion and destruction of the amyloid was
shown unequivocally to be conducted by the MGCs (Bodin
et al., 2010). These unique cells are evidently specifically equip-
ped for this important function. Indeed, the sequence of comple-
ment opsonization, rapidly followed by macrophage invasion
and fusion to form MGCs with strong CR3 expression, which
then engulf and destroy massive amyloid deposits, is entirely
consistent with the present in vitro observations. We have thus
described here key aspects of the cell biology underlying the
role of MGCs in physiological removal from the tissues of
large-scale, abnormal, autologous debris.
The ongoing first clinical trial of anti-SAP antibody therapy in
patients with systemic amyloidosis has confirmed that this inter-
vention causes major complement consumption and produces
rapid, asymptomatic, and clinically beneficial regression of
amyloid deposits (Richards et al., 2015), presumably by trig-
gering macrophage infiltration and MGC formation in humans
as it does in mice. In addition to clinical development, relation-
ships between human MGC function and efficiency of amyloid
clearance in vitro and in vivo are under investigation. More
generally, our work encourages the potential therapeutic
engagement of MGC-mediated clearance in other conditions
caused by abnormal deposition of extracellular materials.
Conversely, specific inhibition of macrophage fusion by inter-
fering with a dominant TH2 environment, for instance via treat-
ments involving clinically approved IL-4 and IL-13 antagonists,
may reduce the pathological conditions associated with the
foreign body reaction whenMGCs are unable to degrade targets
of extrinsic origin.EXPERIMENTAL PROCEDURES
Mice
Wild-type, C3- (Wessels et al., 1995), Itgam-(CD11b) (Melo et al., 2000), and
Itgax-(CD11c) (Wu et al., 2009) knockout (KO) mice as well as human SAP
transgenic mice (Iwanaga et al., 1989) were all on C57BL/6 background. C5-
deficient mice were FVB/N that carries the HC0 locus. All mice were housedhors
under specific pathogen-free conditions. All experiments complied with local
veterinary laws and institutional guidelines.
Phagocytosis Assay
For phagocytosis assays, fused macrophages on Permanox slides (Nunc)
were washed with PBS, and 200 ml serum-free X-VIVO 10 medium (LONZA)
was added to the wells. In experiments involving blocking antibodies or inhib-
itors, these were added at this step. After brief incubation at 37C (humidified;
5% CO2), the slides were cooled on ice, particles were added, and binding by
macrophages was allowed for 30 min. Slides were then returned to 37C to
allow phagocytosis to proceed for defined time periods. Phagocytosis was
stopped by placing the slides back on ice, and unbound particles were
removed bywashing with PBS. Particles not ingested by the cells were stained
by incubation on ice for 20min with primary antibodies specific for the different
opsonins being tested: IgG or C3 on RBCs and OVA or IgG on beads. The
method for inside-outside discrimination of phagocytosis targets was based
on a previously published protocol (Criss and Seifert, 2006). Briefly, fluores-
cently labeled antibodies with selective specificity for the phagocytosis targets
(RBC or beads) were added to the adherent cell cultures without prior cell-fix-
ation or -permeabilization steps to ensure selective access of the antibodies to
external, non-phagocytosed particles only. The procedure thus enables exter-
nally attached (fluorescently labeled) targets to be accurately distinguished
from ingested (non-fluorescently labeled) particles. After washing with PBS,
the cells were fixed for 10 min with 4% w/v paraformaldehyde (PFA) or ice-
cold methanol for RBCs, washed again with PBS, and then stained with the
appropriate fluoresceinated secondary antibodies (15min; on ice). Internalized
0.5-mm beads were visualized after permeabilizing the cells with 0.1% v/v
Triton X-100 in PBS for 5 min at RT, followed by a second round of particle-
specific primary antibodies and differently fluorochrome-labeled secondary
antibodies. Nuclei were counterstained with Hoechst 33258 and slides viewed
by fluorescence microscopy (Leica DMRBE). Representative images were
captured with an AxioCam MRm digital camera using Axiovision software
(Zeiss).
Separation of Mononucleated and Multinucleated Fused
Macrophages
Macrophage fusion was induced on non-treated polystyrene 6-well plates
(Greiner Bio-One). The cells were then detached using 10 mM EDTA in PBS
and passed sequentially through first a 30-mm and then a 10-mm pore size
sieve (Partec). The final flowthrough was a pure population of unfused mono-
nucleated macrophages. The MGCs retained in the 30-mm sieve were flushed
out with alpha-MEM medium containing 10% v/v FCS, and both cell popula-
tions were then resuspended in complete alpha-MEM containing IL-4 and
cultured overnight (37C; humidified; 5% CO2).
Amyloid Studies
Amyloid studies were as previously reported (Bodin et al., 2010) and detailed in
the Supplemental Experimental Procedures.
Statistics
Bar diagrams were constructed using GraphPad Prism 5. Significance of dif-
ferences between groups was sought by unpaired two-tailed Student’s t tests
(GraphPad Prism 5).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
four figures, and four movies and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2015.10.065.
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